This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
C.A. Barry (2006). The role of evidence in alternative medicine: Contrasting biomedical and anthropological approaches. Social Science & Medicine, 62(11), 2646–2657.
V. Butterweck (2003). Mechanism of action of St John’s Wort in depression—What is known? Cns Drugs, 17(8), 539–562.
S.S. Chatterjee , S.K. Bhattacharya , M. Wonnemann , A. Singer , & W.E. Muller (1998). Hyperforin as a possible antidepressant component of hypericum extracts. Life Sciences, 63(6), 499–510.
P. De Smet , & W. Nolen (1996). St John’s Wort as an antidepressant. British Medical Journal, 313(7052), 241–242.
M. Gobbi , & T. Mennini (2005). St John’s Wort and its active principles in depression and anxiety—A critical analysis of receptor binding studies. In W.E. Muller (Ed.), St John’s Wort and its active principles in depression and anxiety. Basel: Birkhauser.
J.W. Harshberger (1896). The purposes of ethnobotany. Botanical Gazette, 21,146–154.
T. Jagtenberg , & S. Evans (2003). Global herbal medicine: A critique. Journal of Alternative and Complementary Medicine, 9(2), 321–329.
C.R. Janes (1999). The health transition, global modernity and the crisis of traditional medicine: The Tibetan case. Social Science & Medicine, 48(12), 1803–1820.
B.D. Kelly (2001). St John’s Wort for depression: What’s the evidence? Hospital Medicine,62(5),274–276.
M.G. Kenny (2002). A darker shade of green: Medical botany, homeopathy, and cultural politics in interwar Germany. Social History of Medicine, 15(3), 481–504.
J. Kim (2006). Beyond paradigm: Making transcultural connections in a scientific translation of acupuncture. Social Science & Medicine, 62(12), 2960–2972.
K. Linde , G. Ramirez , C.D. Mulrow , A. Pauls , W. Weidenhammer , & D. Melchart (1996). St John’s Wort for depression—An overview and meta-analysis of randomised clinical trials. British Medical Journal, 313(7052), 253–258.
A. Maelicke , & H. Lubbert (2002). DEPD, a high resolution gene expression profiling technique capable of identifying new drug targets in the central nervous system. Journal of Receptor Signal Transduction Research, 22(1–4),283–295.
W.E. Müller (Ed.) (2005). St John’s Wort and its active principles in depression and anxiety. Basel:Birkhäuser.
W.E. Müller , A. Singer , M. Wonnemann , U. Hafner , M. Rolli , & C. Schafer (1998). Hyperforin represents the neurotransmitter reuptake inhibiting constituent of Hypericum extract. Pharmacopsychiatry, 31, 16–21.
M. Noldner (2005). Comparative preclinical antidepressant activity of isolated constituents. In W.E. Muller (Ed.) St John’s Wort and its active principles in depression and anxiety. Basel:Birkhauser.
O. Suzuki , Y. Katsumata , M. Oya , S. Bladt , & H. Wagner (1984). Inhibition of monoamine-oxidase by hypericin. Planta Medica, 50 (3), 272–274.
O. Suzuki , Y. Katsumata , M. Oya , V. M. Chari , B. Vermes , H. Wagner , & K. Hostettmann (1981). Inhibition of type A and type B monoamine oxidases by naturally occurring xanthones. Planta Medica, 42(1), 17–21.
C. Timmermann (2001). Rationalizing ‘folk medicine’ in interwar Germany: Faith, business, and science at ‘Dr. Madaus & Co’. Social History of Medicine, 14(3), 459–482.
A. Wahlberg (2008). Above and beyond superstition—Western herbal medicine and the decriminalising of placebo. History of the Human Sciences, 21(1), 77–101.